Antimicrobial stewardship program achieved marked decrease in Clostridium difficile infections in a Veterans Hospital

Am J Infect Control. 2020 Sep;48(9):1119-1121. doi: 10.1016/j.ajic.2019.12.023. Epub 2020 Feb 6.

Abstract

Clostridium (or Clostridioides) difficile infection (CDI) is a common side effect of antimicrobial therapy and is increasingly linked with health care-associated transmissions. Antimicrobial stewardship programs (ASP) have demonstrated success in decreasing in-hospital CDI cases. We implemented an ASP targeting inappropriate or unnecessary use of all antibiotics especially empiric piperacillin-tazobactam and fluoroquinolone use. Concurrently, we monitored all health-care associated CDI. Our CDI cases were markedly decreased after initiation of our ASP.

Keywords: Antimicrobial stewardship; Clostridioides difficile infection; Infection control.

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Antimicrobial Stewardship*
  • Clostridioides difficile*
  • Clostridium Infections* / drug therapy
  • Hospitals, Veterans*
  • Humans
  • United States

Substances

  • Anti-Bacterial Agents